aceRNA Technologies Co.

BiotechnologySeries BKyoto-shi, Japanacernatec.com

Latest round

Series B

Last raised

Dec 2021

Total raised

$2.5M

Investors

3

About aceRNA Technologies Co.

, Ltd. operates as a biotechnology company that develops RNA design technology that can be used in regenerative medicine and gene therapy., Ltd., and Mitsubishi UFJ Capital. The company focuses on RNA Switch technology, utilizing engineered micro RNAs (miRNAs) to precisely target and treat specific cells, minimizing side effects. Its flagship RNA Switch system enhances treatment accuracy for diseases with limited options, with potential uses in both mRNA-based and gene therapies, reducing unintended effects on non-target cells.

Who invested in aceRNA Technologies Co.

3 investors across 2 rounds

See all investors in aceRNA Technologies Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 20, 2021

    Amount

    $2.5M

    Investors

    Locked

  2. Seed

    Nov 9, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about aceRNA Technologies Co.

Who invested in aceRNA Technologies Co.?

aceRNA Technologies Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has aceRNA Technologies Co. raised?

aceRNA Technologies Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did aceRNA Technologies Co. last raise money?

aceRNA Technologies Co.'s most recent round on record is a Series B, in Dec 2021.

What does aceRNA Technologies Co. do?

aceRNA Technologies Co. is a biotechnology company.

Where is aceRNA Technologies Co. headquartered?

aceRNA Technologies Co. is headquartered in Kyoto-shi, Japan.

Which VCs invest in companies like aceRNA Technologies Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at aceRNA Technologies Co.'s stage. Their profiles are linked below.

Raising like aceRNA Technologies Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.